Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LivaNova PLCLIVN · Entity 507 | Director | June 15, 2026 | June 17, 2026 |
| METLIFE INCMET · Entity 488 | EVP & Chief HR Officer | March 01, 2024 | March 05, 2024 |
| Tevogen Inc.TVGN · Entity 7276 | Director | September 11, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LivaNova PLC
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 5,642 |
Ending reported balance
After 2026-06-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-15 · Exercise / conversion · Acquired 4,042 · Balance 6,128 F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Row 2 · 2026-06-15 · Tax withholding · Disposed 486 · Balance 5,642 F3: Shares withheld to satisfy tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-15 · Exercise / conversion · Disposed 4,042 · Balance 0 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,383 |
Reported balance
After 2026-06-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-15 · Grant · Acquired 2,383 · Balance 2,383 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.
F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.
F3: Shares withheld to satisfy tax liability.
F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026.
F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.
METLIFE INC
Report date March 01, 2024 · Filed March 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,794 |
Reported balance
After 2024-03-01 transaction · row 1
1 source rowRow 1 · 2024-03-01 · Tax withholding · Disposed 1,907 · Balance 79,794 F1: Withheld for taxes on shares issued for restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld for taxes on shares issued for restricted stock units.
Tevogen Inc.
Report date September 11, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,678 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Grant · Acquired 75,000 · Balance 123,678 F1: Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 16, 2026 00:05 UTC | Tevogen Inc. TVGN · Entity 7276 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-26-001306 · form4.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,678 F1 · shares: Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates. Read SEC document |
| July 10, 2026 Filed Jul 10, 2026 21:31 UTC | Tevogen Inc. TVGN · Entity 7276 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-26-000994 · form4.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,678 F1 · shares: Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which vests in three equal installments upon the earlier of each of (i) the first anniversary of the grant date and the Issuer having aggregate revenue of $50 million since the grant date, (ii) the second anniversary of the grant date and the Issuer having aggregate revenue of $100 million since the grant date, and (ii) the third anniversary of the grant date and the Issuer having aggregate revenue of $150 million since the grant date, provided that the reporting person remains in service with the Issuer on the applicable vesting date. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000074 · wk-form4_1781726962.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,383 Underlying: Ordinary Shares · 2,383 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F5 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000074 · wk-form4_1781726962.xml · derivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4 · derivative.exercise_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. F4 · derivative.expiration_date: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 486 | $79.70 | $38,734.20 |
DisclosureSEC source: 0001639691-26-000074 · wk-form4_1781726962.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,642 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000074 · wk-form4_1781726962.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · derivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,355 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement. F4 · derivative.exercise_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On December 15, 2024, reporting person was granted RSUs subject to a one-year vesting schedule, which occurred on December 15, 2025. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 269 | $63.06 | $16,963.14 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,086 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:06 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000162 · wk-form4_1766005580.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 4,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000075 · wk-form4_1750193614.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,042 Underlying: Ordinary Shares · 4,042 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F2 · derivative.exercise_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. F2 · derivative.expiration_date: The RSUs, granted under the 2025 Plan, vest on June 15, 2026, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 23:33 UTC | Tevogen Inc. TVGN · Entity 7276 | GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-021220 · form4.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,923 F1 · shares: Represents a grant of restricted stock units ("RSUs") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments beginning on January 1, 2025, provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 22:22 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000147 · wk-form4_1734474144.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,355 Underlying: Ordinary Shares · 2,355 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the award agreement. F2 · derivative.exercise_date: On December 15, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2025, subject to continued service during the vesting period and the award agreement. F2 · derivative.expiration_date: On December 15, 2024, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on December 15, 2025, subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:36 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,907 | $69.73 | $132,975.11 |
DisclosureSEC source: 0001099219-24-000073 · wk-form4_1709674541.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,794 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 12,040 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,040 Underlying: Common Stock · 12,040 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 13,822 | $69.16 | $955,929.52 |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,701 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 26,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,523 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 4,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,555 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 22:27 UTC | Tevogen Inc. TVGN · Entity 7276 | GrantCommon Stock | 193,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-003493 · form4.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,923 F1 · price: On February 14, 2024 (the "Effective Date"), pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each restricted stock unit ("RSU") with respect to shares of Tevogen common stock (each a "Tevogen RSU") that was then unvested was automatically canceled and converted into an award under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan with respect to a number of RSUs to be settled in the common stock of the Issuer equal to the product, rounded up to the nearest whole number, of (i) the number of shares of Tevogen common stock subject to the Tevogen RSU as of immediately prior to the Effective Time, multiplied by (ii) approximately 4.8481. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 23:57 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,981 | $71.27 | $141,185.87 |
DisclosureSEC source: 0001099219-23-000078 · wf-form4_167780140233881.xml · nonDerivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,542 F4 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:57 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 10,979 | $0.00 Strike: $71.73 | $0.00 |
DisclosureSEC source: 0001099219-23-000078 · wf-form4_167780140233881.xml · derivative · entry 5 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,979 Underlying: Common Stock · 10,979 shares Expires 2033-02-27 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:57 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 13,223 | $71.73 | $948,485.79 |
DisclosureSEC source: 0001099219-23-000078 · wf-form4_167780140233881.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,523 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:57 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 29,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-23-000078 · wf-form4_167780140233881.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,746 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:57 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 3,660 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-23-000078 · wf-form4_167780140233881.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,853 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:15 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 3,000 | $71.91 | $215,730.00 |
DisclosureSEC source: 0001099219-22-000205 · wf-form4_167174371072649.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,193 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:51 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,056 | $64.44 | $132,488.64 |
DisclosureSEC source: 0001099219-22-000056 · wf-form4_164634428497246.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,193 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 10,766 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,766 Underlying: Common Stock · 10,766 shares Expires 2032-02-21 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 11,438 | $68.96 | $788,764.48 |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,249 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 26,582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,687 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:58 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 3,590 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-22-000028 · wf-form4_164575066475136.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,105 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:59 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 189 | $58.96 | $11,143.44 |
DisclosureSEC source: 0001099219-21-000099 · wf-form4_161480872789286.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,515 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:59 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 929 | $59.44 | $55,219.76 |
DisclosureSEC source: 0001099219-21-000099 · wf-form4_161480872789286.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,704 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 11,756 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,756 Underlying: Common Stock · 11,756 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 2,934 | $57.43 | $168,499.62 |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,633 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 8,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,567 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 3,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000071 · wf-form4_161429237341434.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,044 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 7,337 restricted stock units previously reported on Table II. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:46 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 29,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000283 · wf-form4_159475959629752.xml · derivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 3,194 restricted stock units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the restricted stock units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the restricted stock units. F4 · derivative.exercise_date: The restricted stock units were granted on July 10, 2017, and vested on July 10, 2020. F4 · derivative.expiration_date: The restricted stock units were granted on July 10, 2017, and vested on July 10, 2020. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:46 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 14,754 | $36.94 | $545,012.76 |
DisclosureSEC source: 0001099219-20-000283 · wf-form4_159475959629752.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,789 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:46 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 29,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000283 · wf-form4_159475959629752.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · derivative · entry 6 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,688 Underlying: Common Stock · 1,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · derivative · entry 5 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550 Underlying: Common Stock · 550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 451 | $44.56 | $20,096.56 |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · nonDerivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 218 | $44.56 | $9,714.08 |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:25 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000127 · wf-form4_158335708465414.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:45 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 4,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000096 · wf-form4_158284709476056.xml · derivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,099 Underlying: Common Stock · 4,099 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. F3 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:45 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 12,296 | $0.00 Strike: $47.58 | $0.00 |
DisclosureSEC source: 0001099219-20-000096 · wf-form4_158284709476056.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,296 Underlying: Common Stock · 12,296 shares Expires 2030-02-24 F1 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017157 · doc4.xml · derivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Underlying: Common Stock · 549 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 187 | $45.66 | $8,538.42 |
DisclosureSEC source: 0001209191-19-017157 · doc4.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 549 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017157 · doc4.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:54 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 4,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014762 · doc4.xml · derivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.